| 000 | 01025 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518031240.0 | ||
| 264 | 0 | _c20200330 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.19.00419 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarr, Paul M | |
| 245 | 0 | 0 |
_aAugmenting Indolent Lymphoma Treatment Options With the Combination of Lenalidomide and Rituximab. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c05 2019 |
||
| 300 |
_a1151-1153 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 | _aLymphoma, Mantle-Cell |
| 650 | 0 | 4 | _aLymphoma, Non-Hodgkin |
| 650 | 0 | 4 | _aRituximab |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 37 _gno. 14 _gp. 1151-1153 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.19.00419 _zAvailable from publisher's website |
| 999 |
_c29506716 _d29506716 |
||